biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Tailwinds Research and Screen Door Manufac

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on May 15, 2023 4:18pm

140 Views

Post# 35448966

RE:Tailwinds Research and Screen Door Manufac

Boomskid wrote: Daniel Carlson of Tailwinds Research and Screen Door Manufacturing is the most pedestrian stock tout who ever foisted himself into the public domain.

You can find Daniel and his Lyins Den here.

Invest with Tailpipe Research and kiss your assets goodbye.

jd

Who are you to talk about "losing money" John.

Please tell how how many thousands upon thousands you and your Minions lost investing in Bioasis.

Yeah....we will happily follow Dan, thank you very much!

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market